March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...
Health Canada licensed psychedelics producer Optimi Health Corp. OPTHF has completed the first batch of its proprietary pre-clinical MDMA drug candidate to be used in drug development, clinical trials ...
EE: Ethinyl estradiol; LNG: Levonorgestrel; OC: Oral contraceptive; RR: Relative risk; VTE: Venous thromboembolism. Transdermal contraceptive patches provide a more convenient delivery system for ...
Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. RVVTF is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback